A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects

Clinical trial NCT03438006 · COMPLETED

Trial details

NCT number: NCT03438006
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Cervical Intraepithelial Neoplasia

Start date: 2018-05-31
Primary completion: 2020-12-03
Enrollment: 3016

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.